Prelude Therapeutics (PRLD)
NASDAQ: PRLD
· Real-Time Price · USD
0.85
-0.01 (-1.16%)
At close: Jun 27, 2025, 1:38 PM
-1.16% (1D)
| Bid | 0.84 |
| Market Cap | 34.78M |
| Revenue (ttm) | 7M |
| Net Income (ttm) | -127.83M |
| EPS (ttm) | -1.68 |
| PE Ratio (ttm) | -0.51 |
| Forward PE | -0.74 |
| Analyst | Buy |
| Ask | 0.85 |
| Volume | 76,207 |
| Avg. Volume (20D) | 172,996 |
| Open | 0.86 |
| Previous Close | 0.86 |
| Day's Range | 0.80 - 0.86 |
| 52-Week Range | 0.61 - 6.80 |
| Beta | 1.24 |
About PRLD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PRLD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PRLD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
2 weeks ago · https://www.defenseworld.net
Two Sigma Investments LP Purchases 174,906 Shares of Prelude Therapeutics Incorporated (NASDAQ:PRLD)Two Sigma Investments LP grew its position in Prelude Therapeutics Incorporated (NASDAQ:PRLD – Free Report) by 307.2% in the fourth quarter, according to its most recent 13F filing with the Secu...
